Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
04/2003
04/02/2003EP1296979A1 Hetaryl-substituted heterocycles
04/02/2003EP1296978A2 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity
04/02/2003EP1296977A1 Heteroaryl-phenyl substituted factor xa inhibitors
04/02/2003EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors
04/02/2003EP1296954A1 Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia
04/02/2003EP1296949A2 Piperidine amides as modulators of chemokine receptor activity
04/02/2003EP1212312B1 Novel derivatives of flavones, xanthones and coumarins
04/02/2003EP1140921B1 4-trifluoromethyl-3-oxazolylpyridines, method for producing them, products containing the same, and their use as pesticides
04/02/2003EP1015446B1 (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents
04/02/2003EP0975220B1 Use of sulfonyloxadiazolones as microbicides
04/02/2003EP0880504B1 Heterocyclo-substituted imidazoles for the treatment of inflammation
04/02/2003EP0865445B1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties
04/02/2003CN1407977A (Hetero) aryl-substituted heterocyclic enaminones, production therof and use thereof as herbicides, acaricides and insecticides
04/02/2003CN1407971A Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
04/02/2003CN1407970A Urea compounds having muscarinic receptor antagonist activity
04/02/2003CN1104429C 4-(3-heterocycly-1-benzoyl) pyrazoles and their use as herbicides
04/02/2003CN1104427C Tricyclic inhibitors of farnesyl protein transferase
04/02/2003CN1104418C Benzoheterocyclic derivatives
04/01/2003US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis
04/01/2003US6541638 (2S,4S)-1-(4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carbonyl)-piperidine-4-carboxylic acid ethyl ester for example; zinc protease inhibitors; for treating diseases associated with vasoconstriction
04/01/2003US6541618 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds
04/01/2003US6541505 Inhibiting the activity of Factor Xa; treating a disease state associated with a physiologically detrimental excess amount of thrombin.
04/01/2003US6541503 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
04/01/2003US6541496 Inhibitors of IMPDH enzyme
04/01/2003US6541489 Excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9, and MMP-13, while exhibiting substantially less inhibition at least of MMP- 1
04/01/2003US6541481 Substituted bicyclic derivatives useful as anticancer agents
04/01/2003US6541476 Piperazine derivatives and their use as anti-inflammatory agents
04/01/2003US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia
04/01/2003US6541471 Useful as a TXA2 receptor antagonist and a 5-HT2 receptor antagonist
04/01/2003US6541467 And at P1 have a six-membered heterocyclic ring having two ring nitrogen ring atoms and the remainder of the ring atoms carbon atoms.
04/01/2003US6541423 Controlling vegatation
04/01/2003CA2288439C Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
03/2003
03/27/2003WO2003024962A1 Piperidine derivatives and their use as modulators of chemokine (especially ccr3) activity
03/27/2003WO2003024955A2 Small molecule inhibitors of caspases
03/27/2003WO2003024949A1 Dna-pk inhibitors
03/27/2003WO2003024948A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists
03/27/2003WO2003024943A2 Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis
03/27/2003WO2003024935A2 Substituted pyrazolyl compounds for the treatment of inflammation
03/27/2003WO2003024929A1 Substituted piperidines with selective binding to histamine h3-receptor
03/27/2003WO2003024899A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE)
03/27/2003WO2003024451A1 2-(2-phenylethyl)-benzimidazole-5-carboxamide derivatives and their use as tryptase inhibitors
03/27/2003WO2003024448A2 Inhibitors of histone deacetylase
03/27/2003WO2003024439A1 Phenethanolamine derivatives for treatment of respiratory diseases
03/27/2003WO2003024401A2 Piperizinones as modulators of chemokine receptor activity
03/27/2003WO2003024220A1 Delta 1-pyrrolines used as pesticides
03/27/2003WO2003002553A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
03/27/2003WO2002101007A3 Antipathogenic benzamide compounds
03/27/2003WO2002098854A3 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
03/27/2003WO2002096358A3 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
03/27/2003WO2002060879A3 Bacterial gyrase inhibitors and uses thereof
03/27/2003WO2002028844A1 Thiazole or oxazole derivatives
03/27/2003WO2002026229A1 Airway mucus secretion inhibitors
03/27/2003US20030060626 Fungicides
03/27/2003US20030060494 Dipeptidyl peptidase IV inhibiting agent; treatment of gastrointestinal disorders
03/27/2003US20030060488 Drug comprising combination
03/27/2003US20030060474 A piperazine compound as antithrombotic agent
03/27/2003US20030060473 Piperazine compounds as inhibitors of MMP or TNF
03/27/2003US20030060470 Ortho, ortho-substituted nitrogen-containing bisaryl compounds, processes for their preparation, their use as medicaments, and pharmaceutical preparation comprising them
03/27/2003US20030060461 Cyclic diamine compound with condensed-ring groups
03/27/2003US20030060455 Treating lung damage from smoke, endometriosis, Behcet's disease, ankylosing spondylitis, cancer, Lyme disease, and/or restenosis following agioplasty with 1-(4-t-butyl-phenyl)-3-(4-(6-morpholin-4-ylmethyl-peperidin-yl)naphthalen-1 -yl)-urea
03/27/2003US20030060453 Such as 4-((4-fluorophenyl)hydrazono)-4H-pyrazole- 3,5-diamine for antiproliferative activity, and promoting apoptosis in cells lacking normal regulation of cell cycle and death
03/27/2003US20030060452 N-heterocyclic derivatives as NOS inhibitors
03/27/2003US20030060418 Serine protease inhibitors
03/27/2003CA2465978A1 Inhibitors of histone deacetylase
03/27/2003CA2460942A1 Substituted pyrazolyl compounds for the treatment of inflammation
03/27/2003CA2459454A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists
03/27/2003CA2454023A1 Dna-pk inhibitors in the treatment of retroviral mediated diseases
03/27/2003CA2423945A1 Restrainers of airway mucus secretion
03/27/2003CA2423885A1 Thiazole and oxazole derivatives
03/26/2003EP1296142A2 Calcium receptor active molecules
03/26/2003EP1295882A1 Process for the preparation of a piperazine derivative
03/26/2003EP1295875A1 Heterocyclic compounds
03/26/2003EP1294716A1 Lactam inhibitors of factor xa and method
03/26/2003EP1294714A2 Thrombin receptor antagonists
03/26/2003EP1294710A1 Indole derivatives useful for the treatment of cns disorders
03/26/2003EP1294707A2 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
03/26/2003EP1294704A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/26/2003EP1294703A1 Process for the preparation of 1,2,4-triazolin-5-one derivatives
03/26/2003EP1294702A1 Benzodiazepine derivatives as app modulators
03/26/2003EP1294700A2 Benzhydryl derivatives
03/26/2003EP1294698A1 Fused azepine derivatives and their use as antidiuretic agents
03/26/2003EP1294690A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
03/26/2003EP1149089B1 PROCESS TO PREPARE TETRAHYDROTHIOPYRAN-o-FLUORINATED CARBAMATES
03/26/2003EP1025085B1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
03/26/2003EP0973756B1 Thiodepsipeptides for combating endoparasites and a method for producing the same
03/26/2003EP0882041B1 Piperazinonephenyloxazolidinone derivatives and their use as antibacterial agents
03/26/2003EP0841926B1 Endothelin receptor antagonists
03/26/2003EP0793656B1 Novel benzyl pyrimidines
03/26/2003CN1406233A Medicine for viral diseases
03/26/2003CN1406231A Pyrimidine compounds
03/26/2003CN1406228A 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
03/26/2003CN1406227A Aryl fused azapolycy clic compounds
03/26/2003CN1406225A Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
03/26/2003CN1405157A Novel diazo alcoholic antifungal compound and its salt
03/26/2003CN1103772C Novel 2,3-disubstituted-4 (3H)-quinazolinone
03/26/2003CN1103770C Quino xaline diones
03/26/2003CN1103756C Estrogenic agents
03/26/2003CN1103590C Use of thiazolidinediones to prevent or delay on set of NIDDM
03/25/2003WO2003000254A1 Fused cyclic compounds and medicinal use thereof
03/25/2003US6537991 A method of treating a peripheral neuropathic pain in a warm-blooded animal requiring such treatment which comprises administering to said animal a therapeutically effective amount of an EP1-type prostaglandin receptor antagonist
1 ... 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 ... 647